Estradiol Patch
Product Images NDC 50090-7986

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 50090-7986). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Estradiol Structural Formula (Image 01)

FDA Label Image

Transdermal Parts (Image 02)

This is a layered structure with a foam backing including an adhesive layer, a polyester film, an acrylate adhesive matrix, and a protective liner containing estradiol. The foam backing provides cushioning and stickiness for application, while the polyester film adds strength. The acrylate adhesive matrix helps in adhesion, and the protective liner ensures the safety and potency of the estradiol contained within.*

FDA Label Image

Figure 1 Mean Serum 17β-estradiol Concentrations Vs. Time Profile Following Application Of A 7.75 Cm2 Transdermal Patch And Application Of A 15.5 Cm2 Estradiol Transdermal System Continuous Delivery (once-weekly) Patch (Image 03)

This text provides a legend for a graph showing the dosage or absorption over time for two types of Estradiol Transdermal System. The legend indicates which line corresponds to which system and can help in interpreting the graph data.*

FDA Label Image

Figure 2 Observed Mean (± S.e.) Estradiol Serum Concentrations For A One Week Application Of The Estradiol Transdermal System Continuous Delivery (once-weekly) (31 Cm2) To The Abdomen And Buttocks Of 38 Postmenopausal Women (Image 04)

FDA Label Image

Figure 3 Mean Percent Change From Baseline In Lumbar Spine (a-p View) Bone Mineral Density By Treatment And Time Last Observation Carried Forward (Image 05)

FDA Label Image

Figure 4 Mean Percent Change From Baseline In Total Hip By Treatment And Time Last Observation Carried Forward (Image 06)

FDA Label Image

Instructions For Use Figure A (Image 07)

Not available.*

FDA Label Image

Instructions For Use Figures B And C (Image 08)

This is a set of instructions for removing an estradiol patch. The text mentions additional tear notches and advises to carefully remove the patch. It also refers to Figures B and C, which likely provide visual guidance for the process.*

FDA Label Image

Instructions For Use Figures D And E (Image 09)

This text is about an estradiol patch for hormone replacement therapy. It mentions protective liners for the patch. The document includes figures labeled as Figure D and Figure E, which presumably depict the estradiol patch and its protective liner.*

FDA Label Image

Instructions For Use Figures F And G (Image 10)

FDA Label Image

Instructions For Use Figure H (Image 11)

FDA Label Image

Label Image (Lbl500907986)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.